Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTERPARFUMS INC Regulatory Filings 2017

Jan 30, 2017

31321_rns_2017-01-30_fa7002f9-68d6-42e0-81b7-1b5354ed52f0.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 v457938_8-k.htm FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 30, 2017

Inter Parfums , Inc. (Exact name of Registrant as specified in its charter)

Delaware 0-16469 13-3275609
(State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, New York 10176 (Address of Principal Executive Offices)

212. 983.2640 (Registrant's Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Field: Page; Sequence: 1

Field: /Page

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated January 30, 2017, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

• Portions of the 1 st paragraph relating to net sales for the fourth quarter of 2016 and the full year ended December 31, 2016

• The 2 nd paragraph relating to net sales for the fourth quarter of 2016 and the full year ended December 31, 2016 (consisting of a table)

• The 3 rd and 4 th paragraphs relating to European operations

• The 5 th paragraph relating to United States operations

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated January 26, 2017, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

• The last sentence of the 1 st paragraph relating to our plans to release operating results for the fourth quarter of 2016 and the full year ended December 31, 2016

• The 6 th paragraph relating to anticipated 2017 new product launches

• The 7 th paragraph relating to 2016 guidance and 2017 guidance

• The 9 th paragraph relating to forward looking information

• The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated January 30, 2017.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: January 30, 2017
By: /s/ Russell Greenberg
Russell Greenberg,
Executive Vice President and Chief Financial Officer

Field: Page; Sequence: 3; Options: Last

Field: /Page